Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00188513
Status:
COMPLETED
Last Update Posted:
2018-06-12
First Post:
2005-09-12
Brief Title:
Intensity Modulated Radiation Therapy - Prostate Cancer
Sponsor:
University Health Network Toronto
Organization:
University Health Network Toronto
Study Overview
Official Title:
A Phase I-II Prospective Trial of Conformal Hypofractionated Intensity Modulated Radiotherapy IMRT for Localized Adenocarcinoma of the Prostate
Status:
COMPLETED
Status Verified Date:
2018-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
There are several different treatment schedules being used across the world for treatment of prostate cancer with radiation therapy In order to determine the best radiation treatment for this disease a study is being performed by the doctors at the Princess Margaret Hospital This study will try to measure the effectiveness and side effects of an increased dose of radiation to the prostate that is also given over a shorter number of weeks than is usually done In order to try to reduce the possible side effects of the radiation therapy the treatment will be given using special techniques to shield as much of your normal body tissues as possible This method of treatment is called conformal intensity modulated radiation therapy or IMRT
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None